This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Aurora Cannabis Inc. (ACB) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) delivered earnings and revenue surprises of -47.37% and -4.99%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Aurora Cannabis (ACB) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Aurora Cannabis' (ACB) sustained consumer cannabis sales are likely to have benefited its performance in the fiscal second quarter.
Cannabis ETFs Spike on Jazz-GW Pharma Deal
by Sweta Killa
Jazz Pharmaceuticals (JAZZ) agreed to buy cannabinoid drug company GW Pharmaceuticals (GWPH) for $7.2 billion in cash and stock that has strengthened the bullish case for the cannabis industry.
Aurora Cannabis Inc. (ACB) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed at $11.20 in the latest trading session, marking a +0.45% move from the prior day.
Aurora Cannabis Inc. (ACB) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $12.04, marking a +0.67% move from the previous day.
Are Options Traders Betting on a Big Move in Aurora Cannabis (ACB) Stock?
by Zacks Equity Research
Investors need to pay close attention to Aurora Cannabis (ACB) stock based on the movements in the options market lately.
Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $10.19, marking a -0.78% move from the previous day.
Aurora Cannabis Inc. (ACB) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed at $9.60 in the latest trading session, marking a -1.34% move from the prior day.
Are Options Traders Betting on a Big Move in Aurora Cannabis (ACB) Stock?
by Zacks Equity Research
Investors need to pay close attention to Aurora Cannabis (ACB) stock based on the movements in the options market lately.
Do Options Traders Know Something About Aurora Cannabis (ACB) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Aurora Cannabis (ACB) stock based on the movements in the options market lately.
Sector ETFs & Stocks to Make the Most of a Divided Congress
by Sweta Killa
As the market is betting on Republicans to continue control the Senate and Democrats the House, most sectors stand to benefit from the scenario.
Aurora Cannabis (ACB) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Aurora Cannabis' (ACB) fiscal first-quarter results are likely to reflect solid prospects in the Canadian market.
Is a Surprise Coming for Aurora Cannabis (ACB) This Earnings Season?
by Zacks Equity Research
Aurora Cannabis (ACB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why Cannabis Stocks & ETFs Are Soaring
by Neena Mishra
Marijuana stocks are rising on hopes of favorable regulatory environment
Zacks Market Edge Highlights: Aurora Cannabis, Canopy Growth, Cronos Group, Innovative Industrial Properties and Constellation Brands
by Zacks Equity Research
Zacks Market Edge Highlights: Aurora Cannabis, Canopy Growth, Cronos Group, Innovative Industrial Properties and Constellation Brands
Is it Finally Time to Buy Marijuana Stocks?
by Tracey Ryniec
With new states set to legalize cannabis this November, and the possibility of federal legalization looming, will the marijuana stocks finally live up to the hype?
Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed at $5.03 in the latest trading session, marking a -1.37% move from the prior day.
Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $4.65, marking a -0.64% move from the previous day.
Is the Options Market Predicting a Spike in Aurora Cannabis (ACB) Stock?
by Zacks Equity Research
Investors need to pay close attention to Aurora Cannabis (ACB) stock based on the movements in the options market lately.
Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed the most recent trading day at $7.07, moving -1.53% from the previous trading session.
Aurora Cannabis (ACB) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Aurora Cannabis' (ACB) fiscal fourth-quarter results likely to reflect solid prospects in the Canadian market.
Aurora Cannabis Inc. (ACB) Stock Moves -0.2%: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed the most recent trading day at $9.80, moving -0.2% from the previous trading session.
Aurora Cannabis Inc. (ACB) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed at $9.51 in the latest trading session, marking a +1.06% move from the prior day.
Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed the most recent trading day at $10, moving -0.99% from the previous trading session.
Aurora Cannabis Inc. (ACB) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed the most recent trading day at $10.02, moving -1.96% from the previous trading session.